Literature DB >> 2990963

Separate site(s) of action of optical isomers of 1-methyl-5-phenyl-5-propylbarbituric acid with opposite pharmacological activities at the GABA receptor complex.

M K Ticku, S K Rastogi, R Thyagarajan.   

Abstract

The behavioral profile of the optical isomers of 1-methyl-5-phenyl-5-propylbarbituric acid (MPPB) and their interaction with the convulsant binding site at the GABA receptor complex were investigated. R(-)-MPPB produced dose-related loss of righting reflex, whereas S(+)MPPB produced convulsions in a dose-dependent manner. Subconvulsive doses of S(+)MPPB were proconvulsant with a subeffective dose of picrotoxin. S(+)MPPB-induced seizures were blocked by R(-)MPPB and pentobarbital. In contrast, S(+)MPPB did not block the loss of righting reflex produced by R(-)MPPB or pentobarbital. S(+)MPPB inhibited the binding of [35S]t-butylbicyclophosphorothionate (TBPS), a ligand that binds to the picrotoxin site on the oligomeric GABA receptor complex, to rat brain membranes competitively, whereas R(-)MPPB inhibited it noncompetitively. Thus, the optical isomer of MPPB, which have opposite pharmacological effects, interact differently with the convulsant (TBPS) site at the GABA receptor complex. These results suggest that the convulsant S(+)MPPB and the depressant R(-)MPPB may produce their behavioral effects by acting via convulsant and anticonvulsant sites, respectively, at the GABA receptor complex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990963     DOI: 10.1016/0014-2999(85)90232-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs.

Authors:  J W Mandema; M Danhof
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

2.  Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.

Authors:  Pavel Y Savechenkov; Xi Zhang; David C Chiara; Deirdre S Stewart; Rile Ge; Xiaojuan Zhou; Douglas E Raines; Jonathan B Cohen; Stuart A Forman; Keith W Miller; Karol S Bruzik
Journal:  J Med Chem       Date:  2012-07-17       Impact factor: 7.446

3.  Thermodynamics and kinetics of t-butylbicyclophosphorothionate binding differentiate convulsant and depressant barbiturate stereoisomers acting via GABAA ionophores.

Authors:  G Maksay; P Molnár; M Simonyi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

4.  Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of heptabarbital using aperiodic EEG analysis.

Authors:  J W Mandema; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

5.  Allosteric modulation of an expressed homo-oligomeric GABA-gated chloride channel of Drosophila melanogaster.

Authors:  A M Hosie; D B Sattelle
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  The discriminative stimulus properties of barbiturate stereoisomers.

Authors:  W D Wessinger; G R Wenger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Contrasting actions of a convulsant barbiturate and its anticonvulsant enantiomer on the α1 β3 γ2L GABAA receptor account for their in vivo effects.

Authors:  Rooma Desai; Pavel Y Savechenkov; Dorota Zolkowska; Ri Le Ge; Michael A Rogawski; Karol S Bruzik; Stuart A Forman; Douglas E Raines; Keith W Miller
Journal:  J Physiol       Date:  2015-11-15       Impact factor: 5.182

8.  Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.

Authors:  David C Chiara; Selwyn S Jayakar; Xiaojuan Zhou; Xi Zhang; Pavel Y Savechenkov; Karol S Bruzik; Keith W Miller; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

9.  Positive and Negative Allosteric Modulation of an α1β3γ2 γ-Aminobutyric Acid Type A (GABAA) Receptor by Binding to a Site in the Transmembrane Domain at the γ+-β- Interface.

Authors:  Selwyn S Jayakar; Xiaojuan Zhou; Pavel Y Savechenkov; David C Chiara; Rooma Desai; Karol S Bruzik; Keith W Miller; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2015-07-30       Impact factor: 5.157

10.  Modulation of the GABAA receptor by depressant barbiturates and pregnane steroids.

Authors:  J A Peters; E F Kirkness; H Callachan; J J Lambert; A J Turner
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.